MedPath

Use of single dose intranasal fentanyl for the reduction of pain in laser photocoagulation for retinopathy of prematurity : a RCT

Phase 3
Not yet recruiting
Conditions
Neonates 32-44 weeks postmenstrual age undergoing laser photocoagulation for retinopathy of prematurity
Registration Number
CTRI/2017/12/011035
Lead Sponsor
Surya Childrens Medicare Pvt Ltd Hospital
Brief Summary

Laser  therapy in premature neonates is associated with significant pain due to eyelid speculum placement for a period of 20-30 min. Standard pain relief measures used in neonates such as oral sucrose, oral paracetamol, proparacaine eye drops, EBM, non nutritive sucking , swaddling, KMC etc may be inadequate in relieving pain associated with laser therapy for ROP.

Intranasal fentanyl is a standard analgesic used in children for severe pain.

We hypothesized that administration of fentanyl intranasally in addition to standard pain relief would result in a further 35% reduction in Pain score (PIPP)in premature neonates undergoing laser therapy. 23 patients would  need to be recruited for a study power of 80% and two tailed alpha of 0.05.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
46
Inclusion Criteria

1.Neonates 32-44 weeks postmenstrual age undergoing laser photocoagulation for retinopathy of prematurity.

Exclusion Criteria
  • 1.Infant receiving sedation or analgesic medications for any reason.
  • 2.Infants on mechanical ventilation.
  • 3.Any congenital malformations, or neurological dysfunction.
  • 4.Parents refusing consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PIPP score (Premature infant pain profile) during laser photocoagulationEvery 10 minutes during procedure
Secondary Outcome Measures
NameTimeMethod
PIPP score,HR,RR1 ,5,10 minutes

Trial Locations

Locations (1)

Surya Child Care PVT. LTD

🇮🇳

(Suburban), MAHARASHTRA, India

Surya Child Care PVT. LTD
🇮🇳(Suburban), MAHARASHTRA, India
Dr jagdish kathwate
Principal investigator
7666490985
docjagdishkat@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.